The Latest News, Updates and Resources
Cellares News
January 11th, 2023 –
Automated Manufacturing Will Deliver More—and Better—Cell Therapies
Business Insider
November 14th, 2022 – Inside The Modular Factory Set To Disrupt Cell Therapy
Einav Kraft recognized on Healthcare Technology Report’s The Top 25 Women Leaders in Biotechnology 2022 list.
November 14th, 2022 – Cellares VP of Quality, Einav Kraft, was…
Will Manufacturing Be the Stumbling Block for T-Cell Therapies?
October 6th 2022 – Immune cellular therapies are poised to bring about a dramatic change in healthcare…
Cellares to tackle key roadblock in cell therapy manufacturing with new partner iVexSol
SOUTH SAN FRANCISCO, Calif., and LEXINGTON, Mass., Sept. 20th, 2022 — Cellares Corporation, a life science…
Fabian Gerlinghaus recognized in Medicine Maker Power List 2022
May 4th, 2022 – South San Francisco – Today, Cellares Co-Founder and CEO, Fabian Gerlinghaus was recognized in the 2022 Power List, celebrating…
Drug Discovery & Development
April 26th, 2022 – How Cellares aims to transform cell therapy manufacturing
Cellares Finishes Year of Strong Growth With Key Hires
December 14th, 2021 – Cellares Corporation, a life sciences technology company pioneering a revolutionary automated approach…
Cellares Appoints Ezekiel Emanuel to Board of Advisors
November 16th, 2021 – Emanuel, Cellares share commitment to lowering cost of care with cell therapies
Biotech Companies are Expanding the Frontiers of Engineered Cell Therapy
November 11th, 2021 – Maggie Chen, BioSpace, featured Cellares’ Cell Shuttle system in her article on unmet needs for cell therapy…
Fabian Gerlinghaus receives 2021 Life Science Catalyst Award
October 27th, 2021 – “The Catalyst Awards recognize the most driven young minds in California who are igniting innovation…”
Cellares Appoints John Tomtishen as Vice President of Operations
October 11th, 2021 – Cellares Corporation, a life sciences technology company pioneering a revolutionary automated…
Forbes
July 28th, 2021 – Scalable Automation is Breaking the Bottleneck on Cell Therapy Manufacturing
Fierce Pharma
July 14th, 2021 – All aboard the Cell Shuttle: Cellares' cell therapy factory-in-a-box project attracts a 3rd partner in Poseida
Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy
July 14th, 2021 – Second industry partner to enter a strategic relationship with Cellares…
GeneOnline
July 14th, 2021 – In Quest For Scalability in Cell Therapy Manufacturing, Cellares Partners with Poseida
Drug Discovery & Development
July 14th, 2021 – Cellares and Poseida partnership aims to accelerate cell therapy manufacturing
Endpoints
July 14th, 2021 – A couple months after landing $100 million in funding, Cellares grabs partner for its Cell Shuttle
BioProcess International
July 14th, 2021 – Poseida joins Cellares’ early-access cell therapy tech program
Fierce Pharma
May 6th, 2021 – Cellares raises $82M to drive work on cell therapy ‘factory-in-a-box’
Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
May 5th, 2021 – Cellares Corporation, a life sciences technology company that automates cell…
Reuters
May 5th, 2021 – Cell therapy manufacturing tech startup Cellares raises $82 million
Endpoints
May 5th, 2021 – Focused on the cell therapy manufacturing bottleneck, Cellares turbocharges plans for ‘shuttle’ tech
Crunchbase
May 5th, 2021 – Cellares secures $82M Series B To Address Cell Therapy Manufacturing Obstacles. Life sciences technology…
MedCity News
May 5th, 2021 – Cellares gets $82M to make cell therapy manufacturing automated, scalable. Cell therapy manufacturing is currently…
BioProcess International
April 26th, 2021 – Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation…
Fabian Gerlinghaus featured in Medicine Maker Power List 2021
April 15th, 2021 – South San Francisco – Today, Cellares Co-Founder and CEO, Fabian Gerlinghaus was recognized in the 2021 Power List, celebrating…
Cellares Appoints Dr. Rodney L. Rietze to Advisory Board
February 11th, 2021 – South San Francisco – Cellares Corporation, a biotechnology company focused on revolutionizing cell therapy manufacturing…
CAR-T Sector Seeks Tech Boost to Meet Anticipated Demand
February 8th, 2021 – Products from Novartis and Gilead proved it was possible to win regulatory approval for chimeric antigen receptor T cell…
Spearheading a Paradigm Shift in Cell Therapy Manufacturing
January 25th, 2021 – Cell therapies are revolutionizing modern medicine. Where traditional treatment methods have failed, cell therapies…
Cellares Adds PACT Pharma to its Early Access Partnership Program
South San Francisco – January 8th, 2021 – Cellares Corporation, a company focused on revolutionizing cell therapy manufacturing…
Einav Kraft joins Cellares as Vice President of Quality
December 2nd, 2020 – South San Francisco – Cellares Corporation, a biotechnology company focused on revolutionizing cell therapy manufacturing, announced…
Cellares Welcomes Fred Hutchinson Cancer Research Center Into Its Early Access Partnership Program
October 29th, 2020 – Cellares Corporation, a biotechnology company focused on revolutionizing cell…
Cellares – Evolving the Pharmaceutical Manufacturing Industry
October 29th, 2020 – Living with Stage IV cancer is a dual reality – one reality is counting your days left…
Mark Flower joins Cellares as Vice President of Business Development
May 8th, 2020 (South San Francisco) Cellares, an organization developing a next-generation cell therapy…
Cellares Fact Sheet